Mead Johnson Nutritionals Enfamil formula posts third quarter 6% rise to $165 mil..
This article was originally published in The Tan Sheet
Executive Summary
BRISTOL-MYERS' MEAD JOHNSON NUTRITIONALS SALES RISE 10% TO $443 MIL. in the third quarter, Bristol- Myers Squibb reported Oct. 22. Excluding the effects of foreign exchange, Mead Johnson would have posted an 11% sales gain, BMS noted. Sales of nutritionals were led by Enfamil, the firm's best-selling formula, which had revenues of $165 mil. in the third quarter, an increase of 6% from the year-earlier period.